No Cover Image

Journal article 363 views

Long-term safety and efficacy of linagliptin as monotherapy or in combination with other oral glucose-lowering agents in 2121 subjects with type 2 diabetes: up to 2 years exposure in 24-week phase III trials followed by a 78-week... / David, Owens

International Journal of Clinical Practice, Volume: 66, Issue: 8, Pages: 731 - 740

Swansea University Author: David, Owens

Full text not available from this repository: check for access using links below.

Published in: International Journal of Clinical Practice
ISSN: 1368-5031
Published: 2012
Online Access: Check full text

Tags: Add Tag
No Tags, Be the first to tag this record!
College: Swansea University Medical School
Issue: 8
Start Page: 731
End Page: 740